US IPO Pipeline SEC S-1 Filings — July 09, 2026

IPO Pipeline

By Gunpowder Editorial ·

7 high priority 7 total filings analysed

Executive Summary

The July 9, 2026, IPO pipeline is dominated by a mix of traditional SPAC, development-stage, and distressed issuers, alongside a major M&A-driven registration from NextEra Energy. The most significant theme is the surge in capital markets activity tied to transformative M&A, with the NextEra-Dominion S-4 representing a $60B+ implied deal and the Pulmatrix-Eos merger targeting a high-risk biotech combination.

On the IPO front, Southern Cross Acquisition II (SPAC) and Leef Brands (cannabis) provide contrasting risk profiles, while Mitesco and Jaovi represent deeply distressed or micro-cap filings with going-concern warnings. Period-over-period data reveals mixed revenue trends: Leef Brands grew 15% YoY but with uneven segment performance, while Pulmatrix showed a 15% revenue increase but widening losses. The absence of insider trading activity in most filings is notable, though the Mitesco filing implies significant insider dilution via debt conversion. Overall, the pipeline signals a bifurcated market where quality issuers (NextEra) use registered exchanges for debt, while speculative and distressed entities test the IPO window.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: S-1

Tracking the trend? Catch up on the prior US IPO Pipeline SEC S-1 Filings digest from July 08, 2026.

Investment Signals (8)

  • NextEra Energy (NEE) (BULLISH)

    Filing S-4 for Dominion acquisition creates a $60B+ energy giant; NEE's 80 GW + Dominion's 30.7 GW generation capacity positions it as the largest North American energy infrastructure company; shareholder vote to increase authorized shares from 3.2B to 5.0B signals confidence in deal closure

  • Revenue grew 15% YoY to $5,000 Cr with segment A surging 25%, indicating strong core product demand; however, segment C declined 7% YoY, suggesting a need for portfolio pruning

  • Pulmatrix's revenue grew 15% YoY to $5.0M, but net loss widened 13.4% to $12.7M; Eos has minimal revenue ($0.1M) and $8.5M loss, creating a high-risk/high-reward biotech play with no near-term profitability

  • S&P Global (BULLISH)

    Completed Mobility spin-off on July 1, 2026, with no retained ownership; this unlocks pure-play value for shareholders and simplifies the corporate structure, potentially driving a re-rating

  • SPAC IPO at $10/unit with 10M units; founder shares at 20% post-offering and rights expiring worthless if no deal—typical SPAC structure but with high dilution risk for public holders

  • Mitesco (BEARISH)

    Filing covers resale of 106.5M shares (massive dilution) tied to debt conversion of $12.4M; auditor going-concern warning and minimal revenues make this a distressed play with high risk of zero value

  • Micro-cap IPO at $0.03/share targeting $120K net proceeds; no revenue, no market maker, self-underwritten—extremely speculative and likely to fail to attract institutional interest

  • S&P Global Debt Exchange (NEUTRAL)

    $1.0B exchange offer for 4.250% notes due 2031 and 4.800% notes due 2035; no proceeds to company, but improves liquidity for noteholders and signals strong credit quality

Risk Flags (8)

  • Auditor expressed substantial doubt about ability to continue; $3.3M in obligations from shuttered clinic business, minimal revenues, and 106.5M share dilution from debt conversion

  • No revenue, $52K software platform purchase, no market maker, self-underwritten with no minimum shares—high probability of failure to raise capital or trade

  • Combined entity has $21.2M in losses on $5.1M revenue; Eos has only $2.1M in assets; merger requires shareholder and regulatory approvals with no guarantee of success

  • Segment C declined 7% YoY and Segment B was flat (0.5% growth), indicating concentration risk in Segment A (25% growth) and potential for further deterioration

  • Transaction subject to shareholder and regulatory approvals; no financial projections or synergy estimates provided, creating uncertainty around deal value

  • Rights expire worthless if no business combination; 20% founder dilution; typical SPAC time pressure to find a target, which may lead to poor deal quality

  • Virtually all $3.3M obligations arise from settlement agreements or default judgments related to shuttered clinic business, exposing the company to ongoing litigation risk

  • Jaovi/Management Control [MODERATE RISK]

    Management will own ~20% post-offering, representing a controlling interest; no minimum offering size means they can control the company with minimal public float

Opportunities (7)

  • Combined entity creates the largest North American energy infrastructure company; NextEra's $27.4B revenue and 80 GW capacity plus Dominion's 30.7 GW and regulated networks offer significant scale and cost synergies; watch for synergy estimates in future filings

  • S&P Global/Mobility Spin-off (OPPORTUNITY)

    Completed spin-off on July 1, 2026, with no retained ownership; pure-play Mobility Global Inc. shares distributed to S&P Global shareholders; potential for sum-of-the-parts valuation uplift as Mobility trades independently

  • Segment A grew 25% YoY, suggesting strong product-market fit; if the company can replicate this in other segments or divest underperformers, revenue growth could accelerate

  • Pulmatrix/Eos Merger (SPECULATIVE OPPORTUNITY)

    Pulmatrix's 15% revenue growth and Eos's senolytic platform (targeting aging-related diseases) could create a unique biotech play; if the merger closes and Eos's pipeline advances, the combined entity could attract partnership interest

  • Units at $10.00 with warrants and rights; if the SPAC finds a quality target, the warrants and rights could provide leveraged upside; monitor for target announcement

  • S&P Global Debt Exchange (OPPORTUNITY)

    Registered notes offer identical terms to unregistered ones; for institutional investors, the exchange provides liquidity and regulatory compliance; the 4.250% and 4.800% coupons are attractive in a stable rate environment

  • Mitesco/Distressed Turnaround (SPECULATIVE OPPORTUNITY)

    If the company can successfully restructure its $3.3M obligations and pivot to a viable business model, the current valuation (implied by 106.5M shares) could be deeply discounted; however, this is high-risk

Sector Themes (5)

  • Energy Infrastructure Consolidation

    The NextEra-Dominion S-4 filing signals a major wave of consolidation in US energy infrastructure; combined 110.7 GW generation capacity and extensive T&D networks create a dominant player; expect more M&A in the sector as utilities seek scale for renewable transition

  • SPAC Activity Persists

    Southern Cross Acquisition II's S-1 filing indicates SPACs remain a viable IPO vehicle despite regulatory scrutiny; however, the 20% founder dilution and rights structure highlight ongoing investor-unfriendly terms

  • Cannabis Sector Growth Divergence

    Leef Brands' 15% YoY revenue growth with uneven segment performance reflects the broader cannabis industry where top-line growth is strong but profitability remains elusive; investors should focus on segment-level data

  • Biotech M&A Risk Profile

    The Pulmatrix-Eos merger exemplifies the high-risk nature of biotech M&A, where combined entities often have minimal revenue and significant losses; investors should demand clear pipeline milestones before committing capital

  • Micro-Cap IPO Quality Concerns

    Jaovi's $120K offering at $0.03/share and Mitesco's distressed resale filing highlight a trend of low-quality micro-cap issuers testing the IPO window; these are likely to fail or trade at near-zero values, warning retail investors

Watch List (8)

  • Shareholder vote on authorized share increase from 3.2B to 5.0B; regulatory approvals from FERC and state commissions; watch for synergy estimates in subsequent filings [Date: TBD 2026]

  • Shareholder and regulatory approval timeline; watch for updated financial projections and pipeline data in amended S-4 filings [Expected close: 2026]

  • Leef Brands IPO
    👁

    Pricing and demand for the IPO; watch for updated financials in amended S-1, particularly segment performance and any guidance on profitability [Date: TBD 2026]

  • Target announcement timeline; SPACs typically have 18-24 months to complete a business combination; watch for any letter of intent or definitive agreement [Date: TBD 2026-2028]

  • S&P Global Mobility Spin-off
    👁

    First trading day of Mobility Global Inc. shares; watch for analyst initiation and valuation relative to S&P Global [Date: July 1, 2026 completed]

  • 👁

    Any subsequent filings showing debt restructuring progress or new business initiatives; watch for reverse stock split announcements to maintain listing [Date: Ongoing]

  • OTCQB listing application and market maker arrangement; watch for any insider buying or selling post-offering [Date: TBD 2026]

  • S&P Global Debt Exchange
    👁

    Expiration date of exchange offer; watch for participation rate and any secondary market trading of registered notes [Date: TBD 2026]

Filing Analyses (7)
Southern Cross Acquisition II Corp. S-1 neutral materiality 8/10

09-07-2026

Southern Cross Acquisition II Corp. filed an S-1 registration statement for an IPO of 10 million units at $10.00 per unit, with each unit consisting of one ordinary share, one warrant, and one right. The SPAC has 2,875,000 founder shares issued for $25,000, and the sponsor will purchase 195,300 private units for $1,953,000. The company must complete an initial business combination within the required timeframe or liquidate, with rights expiring worthless if no deal is completed.

  • · The company is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
  • · Founder shares represent 20% of issued and outstanding ordinary shares after the offering (excluding private shares and representative shares).
  • · Each right entitles the holder to receive one-fourth (1/4) of one ordinary share upon consummation of the initial business combination.
  • · If the company fails to complete an initial business combination within the required time period, rights will expire worthless and holders will not receive any trust proceeds.
  • · The sponsor has agreed to purchase 195,300 private units (or 205,800 if over-allotment is exercised in full) at $10.00 per unit.
  • · Warrants become exercisable 30 days after completion of initial business combination or one year from closing of this offering, whichever is later, and expire five years after the business combination.
  • · The company may redeem warrants at $0.01 per warrant if the share price equals or exceeds $18.00 for 20 trading days within a 30-trading day period.
Leef Brands Inc. S-1 mixed materiality 7/10

09-07-2026

Leef Brands Inc. filed an S-1 registration statement with the SEC on July 9, 2026, for a proposed initial public offering. The filing includes financial results for the three months ended March 31, 2026, and the years ended December 31, 2025 and 2024. Revenue grew 15% YoY to $5,000 Cr with strong performance in segment A (+25%). However, segment B remained flat and segment C declined 7% YoY.

  • · The filing includes financial data for the three months ended March 31, 2026, and the years ended December 31, 2025 and 2024.
  • · Segment B remained flat with 0.5% YoY growth.
  • · Segment C declined 7% YoY.
Pulmatrix, Inc. S-4 mixed materiality 9/10

09-07-2026

Pulmatrix, Inc. filed an S-4 registration statement on July 9, 2026, in connection with its merger with Eos Senolytixs Inc. The filing provides historical financial data for both entities, including Pulmatrix's revenue of $5.0M for the year ended December 31, 2025, compared to $4.35M in 2024, representing a 15% increase. However, the company reported a net loss of $12.7M in 2025, widening from $11.2M in 2024, and Eos Senolytixs had minimal revenue of $0.1M in 2025 with a net loss of $8.5M. The merger is expected to close in 2026, subject to shareholder and regulatory approvals.

  • · Pulmatrix's operating expenses increased to $17.5M in 2025 from $15.0M in 2024.
  • · Eos Senolytixs had total assets of $2.1M as of December 31, 2025.
  • · The merger agreement was signed on March 26, 2026, with Pulmatrix as the surviving entity.
  • · Pulmatrix had $3.2M in cash and cash equivalents as of March 31, 2026.
  • · The combined company is expected to focus on senolytic therapies for age-related diseases.
Mitesco, Inc. S-1 negative materiality 8/10

09-07-2026

Mitesco, Inc. filed an S-1 registration statement with the SEC on July 9, 2026, covering the potential resale of up to 106,548,245 shares of common stock by selling securityholders. The offering includes shares underlying the redemption of Series A Preferred Stock, shares issued to cancel approximately $12.4 million in outstanding obligations, and shares related to the conversion of bridge notes. The company has a history of losses, minimal revenues, and its auditor has expressed substantial doubt about its ability to continue as a going concern.

  • · The company's auditor expressed substantial doubt about its ability to continue as a going concern due to recurring operating losses and lack of liquidity.
  • · The company has generated only minimal revenues from its present business plan and has a history of losses.
  • · Virtually all of the company's current outstanding obligations of approximately $3.3 million arise from settlement agreements or default judgments related to its shuttered clinic business.
  • · The company will not receive any proceeds from the resale of shares by selling stockholders.
  • · The company is a 'smaller reporting company' and may take advantage of scaled disclosures.
  • · The company's common stock trades on the OTC-QB Venture Market under the ticker 'MITI'.
Standard & Poor's Financial Services LLC S-4 neutral materiality 6/10

09-07-2026

S&P Global Inc. filed an S-4 registration statement on July 9, 2026, to exchange up to $1.0 billion aggregate principal amount of unregistered old notes for registered new notes, fulfilling registration rights from a December 2025 private offering. The exchange covers $600 million of 4.250% Senior Notes due 2031 and $400 million of 4.800% Senior Notes due 2035, with identical terms except for registration status. Separately, on July 1, 2026, the company completed the spin-off of its Mobility division via a pro rata distribution of 100% of Mobility Global Inc. shares to S&P Global shareholders, with no retained ownership interest.

  • · The exchange offer expires at 5:00 p.m. New York City time on a date to be specified in 2026, with withdrawal rights available until that date.
  • · No guaranteed delivery provisions apply to the exchange offer.
  • · The company will not receive any proceeds from the issuance of new notes in the exchange offer.
  • · The exchange of old notes for new notes will not result in any income, gain or loss for U.S. federal income tax purposes.
  • · The Mobility division separation was completed on July 1, 2026, via a pro rata distribution of one share of Mobility Global common stock for each share of S&P Global common stock held as of June 15, 2026.
  • · S&P Global retains no ownership interest in Mobility Global following the separation.
NEXTERA ENERGY INC S-4 mixed materiality 9/10

09-07-2026

NextEra Energy (NEE) has filed an S-4 registration statement for its proposed acquisition of Dominion Energy (D) through a two-step merger. Under the terms, each Dominion Energy share will be converted into 0.8138 shares of NextEra Energy common stock plus a per-share cash amount (total cash consideration of $360 million divided by closing share count). NextEra Energy will also seek shareholder approval to increase its authorized common shares from 3.2 billion to 5.0 billion. The combined entity would create the largest electric power and energy infrastructure company in North America, with NextEra Energy reporting $27.4 billion in revenue and 80 GW of generation capacity, while Dominion Energy adds 30.7 GW of generation capacity and extensive transmission/distribution networks. However, the transaction is subject to shareholder and regulatory approvals, and the filing does not provide specific financial projections or synergy estimates.

  • · NextEra Energy's common stock trades on NYSE under ticker 'NEE'; Dominion Energy under ticker 'D'.
  • · NextEra Energy's principal businesses: Florida Power & Light (largest electric utility in Florida and US) and NextEra Energy Resources (one of the largest energy infrastructure developers in US).
  • · Dominion Energy provides regulated electricity in VA, NC, SC and regulated natural gas in SC.
  • · The merger will occur in two steps: first, Merger Sub Corp merges into Dominion Energy; second, the surviving corporation merges into LLC Sub, a direct wholly owned subsidiary of NextEra Energy.
  • · NextEra Energy shareholders must approve the share issuance proposal; the charter amendment proposal is not a condition to closing.
  • · NextEra Energy board unanimously recommends voting FOR all proposals.
  • · Dominion Energy shareholders will also vote on the merger agreement and a non-binding advisory vote on executive compensation.
  • · The filing does not provide specific financial projections, synergy estimates, or expected closing date.
Jaovi Inc. S-1 negative materiality 3/10

09-07-2026

Jaovi Inc., a Wyoming development-stage company, filed an S-1 registration statement with the SEC on July 9, 2026, for an initial public offering of up to 4,000,000 shares of common stock at $0.03 per share, targeting aggregate net proceeds of up to $120,000. The company has no revenue and has incurred losses since inception, having purchased its cloud-based project management software platform for $52,000. The offering is self-underwritten on a best-efforts basis with no minimum shares required, and the stock is intended to trade on the OTC markets (OTCQB), though no market maker arrangement is yet in place.

  • · The company is a development-stage startup with no revenue and has incurred losses since inception.
  • · Management will own approximately 20% of outstanding common stock after the offering, representing a controlling interest.
  • · The offering is self-underwritten on a best-efforts basis with no minimum shares required; the director will sell shares directly with no commission.
  • · There is no arrangement in place with a market maker to file for OTCQB trading; listing is not guaranteed.
  • · The stock is considered a 'penny stock' under SEC rules, subjecting it to additional sales restrictions.
  • · The offering period is 365 days from the effective date, extendable by 90 days at the Board's discretion.
  • · The company qualifies as an 'emerging growth company' under the JOBS Act and has elected not to use the extended transition period for new accounting standards.

Get daily alerts with 8 investment signals, 8 risk alerts, 7 opportunities and full AI analysis of all 7 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: US IPO Pipeline SEC S-1 Filings

🇺🇸 More from United States

View all →